8-K 1 g79270e8vk.txt QUINTILES TRANSNATIONAL 8-K SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 11, 2002 QUINTILES TRANSNATIONAL CORP. (Exact name of registrant as specified in its charter) NORTH CAROLINA 000-23520 56-1714315 (State or other (Commission File No.) I.R.S. Employer jurisdiction Identification Number of incorporation) 4709 CREEKSTONE DRIVE, RIVERBIRCH BUILDING, SUITE 200, DURHAM, NORTH CAROLINA 27703-8411 (Address of principal executive offices) (919) 998-2000 (Registrant's telephone number, including area code) N/A (Former name or former address, if changed since last report) ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.* (c) Exhibits Exhibit Number Description of Exhibit -------------- ---------------------- 99.01 Press Release, dated November 11, 2002, of Quintiles Transnational Corp. ITEM 9. REGULATION FD DISCLOSURE.* On November 11, 2002, Quintiles Transnational Corp. (the "Company") issued a press release in which the Special Committee of its Board of Directors announced that it had rejected the proposal by Pharma Services Company, an entity wholly owned by Dennis B. Gillings, Ph.D., Chairman of the Board and Founder of the Company, to acquire all outstanding shares of the Company's common stock. A copy of the press release is attached hereto as Exhibit 99.01 and incorporated by reference herein. * The information in this Current Report on Form 8-K, including the exhibit, is furnished pursuant to Item 9 and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section. Furthermore, the information in this Current Report on Form 8-K, including the exhibits, shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. QUINTILES TRANSNATIONAL CORP. By: /s/ James L. Bierman ------------------------ Dated: November 12, 2002 James L. Bierman Chief Financial Officer EXHIBIT INDEX Exhibit Number Description of Exhibit -------------- ---------------------------- 99.01 Press Release, dated November 11, 2002, of Quintiles Transnational Corp.